Receiving-site gap assessmentQuality agreement reviewFirst-lot release records
Home / Scoping a Peptide Technology Transfer Service

Scoping a Peptide Technology Transfer Service

Prepare a comparable brief for a potential receiving CDMO, from document ownership to the first acceptance decision.

What exactly is moving between organisations?

Describe the material using its approved business identifier and define which parts of the project the receiving organisation is expected to take over. A transfer can cover analytical records alone, an agreed production scope, or a wider set of quality and supply responsibilities. Name the sending organisation, receiving organisation and buyer representative. The WHO pharmaceutical transfer guidance distinguishes sending and receiving units, a useful starting point for outlining an enquiry.

WHO (2022) · Technology transfer in pharmaceutical manufacturing, TRS 1044 Annex 4

Two operators in blue protective clothing guide a sheet over a metal work surface.
Sheet handling at the worktableThe sheet and work surface provide context for recording the handling stage associated with an inspected unit.
Image creditsCompany footage
A circular feed bowl and guide rails are visible beside a row of containers.
Container feed and guide railsThe overview distinguishes container handling from the separate decision to release a particular lot.
Image creditsCompany footage

What can a supplier quote today?

Separate a document review from the later work that depends on its findings. Ask for a statement of available inputs, assumptions, deliverables and exclusions for each stage. If the originating organisation has not released an important report, name its owner and the decision it delays. Give each bidder the same deliverable definition so a shorter timeline cannot hide an unquoted stage of the transfer.

HYTAN · Peptide CDMO service categories and project brief

Who signs the first decision?

Imagine that one bidder treats a successful file review as project completion while another includes a receiving-site assessment and signed summary. Ask both to show the decisions included in the estimate and the role responsible for acceptance. Define a first milestone the buyer can verify, such as an indexed handover with named gaps and document owners. Preserve later production commitments as separate decisions. This makes the first purchase meaningful even if the receiving organisation identifies additional work.

FDA (2016) · Quality agreements in contract drug manufacturing

Worked example

Two buyers may expect different deliverables from a single transfer review meeting. One wants a discussion and the other needs an approved action record. Put the agenda, document owner, expected signatories and due date for the record in the proposed scope before accepting the fee.

Prepare your inquiry

Quote the scope by decision and identify who can accept each deliverable.

Select the items you want to ask about.

Certificates of analysis

For a transferred lyophilized powder project, compare the issuing site, lot identifier and certificate version with the agreed first-lot release record.

Read a COA